iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Unusually-High Trading Volume – Should You Buy?

Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw unusually-high trading volume on Thursday . Approximately 568,917 shares traded hands during trading, an increase of 426% from the previous session’s volume of 108,206 shares.The stock last traded at $100.09 and had previously closed at $98.29.

iShares U.S. Pharmaceuticals ETF Trading Up 1.7%

The firm has a 50 day moving average price of $91.12 and a 200 day moving average price of $88.56. The stock has a market capitalization of $1.12 billion, a PE ratio of 17.75 and a beta of 0.49.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Foundations Investment Advisors LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at about $54,513,000. BNP Paribas Financial Markets bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at approximately $13,108,000. Anfield Capital Management LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $10,007,000. JPMorgan Chase & Co. increased its holdings in iShares U.S. Pharmaceuticals ETF by 89.4% in the 4th quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock worth $18,052,000 after acquiring an additional 100,426 shares in the last quarter. Finally, Cetera Investment Advisers raised its stake in iShares U.S. Pharmaceuticals ETF by 675.4% during the 1st quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock worth $9,489,000 after acquiring an additional 95,353 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.